Interestingly, these metabolic alterations elicited by CDE-metabolite were independent of oncogenic KRAS in pancreatic cancer, suggesting CAFs’ ability to reprogram and support cancer cell metabolism independent of oncogene activation (117). The gene discussed is KRAS; the disease is cancer.